TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Robert Cook-Deegan’s Viewers’ Guide To the Super Bowl of Gene Patent Cases March 14, 2014
TCL Archive Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval January 27, 2006
